FDAnews
www.fdanews.com/articles/72669-crucell-and-dsm-announce-per-c6-license-agreement-with-ferring

Crucell and DSM Announce PER.C6 License Agreement with Ferring

May 25, 2005

Dutch biotechnology company Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6 commercial license agreement with Ferring Pharmaceuticals. This license agreement allows Ferring to use the PER.C6 cell line in the field of women's healthcare. Financial details were not disclosed.

()a href="http://biz.yahoo.com/pz/050525/78854.html" target="_blank">Yahoo News